Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire January 22, 2026 CONSHOHOCKEN, Pa., Jan. 22, 2026 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on January 15, 2026 to 40 new […]

Hub Group Schedules Fourth Quarter 2025 Earnings Conference Call GlobeNewswire January 22, 2026 OAK BROOK, Ill., Jan. 22, 2026 (GLOBE NEWSWIRE) — Hub Group, Inc. (Nasdaq: HUBG) will hold a conference call at 5:00 p.m. Eastern Time on Thursday, February 5, 2026, to discuss fourth quarter 2025 results. The results will be announced via press

Nukkleus Inc. Provides Updates on Acquisitions and Outlines Its 2026 Growth Strategy Current portfolio estimated to generate revenues of $20-22 million in 2026 GlobeNewswire January 22, 2026 NEW YORK and TEL AVIV, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) — Nukkleus Inc. (NASDAQ: NUKK) (“Nukkleus” or the “Company”), a strategic acquirer and developer of high-potential businesses

CTO Realty Growth Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call Information GlobeNewswire January 22, 2026 WINTER PARK, Fla., Jan. 22, 2026 (GLOBE NEWSWIRE) — CTO Realty Growth (NYSE: CTO) (the “Company”) announced today that it will report its financial and operating results for the fourth quarter and full year of

CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population Study is Expected to Be One of the Largest Therapeutic Cardiac Device Trials in Heart Failure Ever Performed, and is Supported by CMS Category B IDE Coverage GlobeNewswire January 22, 2026 MINNEAPOLIS, Jan. 22, 2026 (GLOBE NEWSWIRE) — CVRx,

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 GlobeNewswire January 22, 2026 SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat

Alpha Modus Announces Resolution of Patent Litigation with Mood Media GlobeNewswire January 22, 2026 CORNELIUS, N.C., Jan. 22, 2026 (GLOBE NEWSWIRE) — Alpha Modus, Corp., a subsidiary of Alpha Modus Holdings, Inc. (“Alpha Modus”) (NASDAQ: AMOD), today announced that it has resolved its patent litigation against Mood Media, LLC. The matter has been dismissed with

Peloton Interactive, Inc. Announces Date of Second Quarter Fiscal 2026 Earnings Release and Conference Call GlobeNewswire January 22, 2026 NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) — Peloton Interactive, Inc. (NASDAQ: PTON) will release its second quarter fiscal 2026 financial results before the U.S. stock market opens on Thursday, February 5, 2026. The company will

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units GlobeNewswire January 22, 2026 ATHENS, Greece, Jan. 22, 2026 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (the “Partnership”) (NYSE: “DLNG”), an owner and operator of LNG carriers, today announced that its Board of Directors has declared a cash distribution of $0.5625 per

LiveRamp to Discuss Third Quarter FY26 Financial Results GlobeNewswire January 22, 2026 SAN FRANCISCO, Jan. 22, 2026 (GLOBE NEWSWIRE) — LiveRamp(R) (NYSE: RAMP), the leading global data collaboration platform, today announced that its fiscal 2026 third quarter financial results will be released on Thursday, February 5, 2026 after the financial markets close. A conference call